<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zheng, Jieling</style></author><author><style face="normal" font="default" size="100%">Zhang, Bin</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh &lt;em&gt;et al&lt;/em&gt;</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2022-05-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">e004965</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2022-004965</style></doi><volume><style face="normal" font="default" size="100%">10</style></volume><issue><style face="normal" font="default" size="100%">5</style></issue><abstract><style  face="normal" font="default" size="100%">You do not have access to the full text of this article, the first page of the PDF of this article appears above.</style></abstract></record></records></xml>